Related Experiment Video
Updated: Feb 6, 2026

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
Published on: September 8, 2021
The α-Cyclodextrin/Moringin Complex: A New Promising Antimicrobial Agent against Staphylococcus aureus
Letizia Romeo1, Veronica Lanza Cariccio2, Renato Iori3
1IRCCS Centro Neurolesi "Bonino-Pulejo", Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy. letizia.romeo@hotmail.it.
Moringin (MOR) complexed with alpha-cyclodextrin (α-CD) shows antimicrobial activity against Staphylococcus aureus. This MOR/α-CD complex is effective against antibiotic-resistant strains, offering a potential new therapeutic strategy.
Area of Science:
- Pharmacology
- Microbiology
- Natural Products Chemistry
Background:
- Antimicrobial resistance (AMR) is a significant global health threat, necessitating novel therapeutic agents.
- Moringin (MOR), derived from Moringa oleifera seeds, presents a potential alternative to conventional antibiotics due to its isothiocyanate structure.
Purpose of the Study:
- To evaluate the antimicrobial efficacy of moringin conjugated with alpha-cyclodextrin (MOR/α-CD).
- To assess the potential of MOR/α-CD as a therapeutic agent against antibiotic-resistant bacteria, specifically Staphylococcus aureus.
Main Methods:
- Preparation and characterization of MOR/α-CD complex.
- Determination of minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) against S. aureus reference strains.
- Evaluation of MOR/α-CD activity against erythromycin-induced clindamycin-resistant S. aureus (erm(A) gene).
Main Results:
- MOR/α-CD demonstrated significant antimicrobial activity against S. aureus reference strains.
- MIC was determined to be 0.5 mg/mL and MBC was 1 mg/mL, indicating bacteriostatic and bactericidal effects.
- MOR/α-CD exhibited bactericidal activity against a clindamycin-resistant S. aureus strain (ATCC BAA-977).
Conclusions:
- MOR/α-CD possesses notable antimicrobial properties against S. aureus.
- The complex shows promise as a potential therapeutic agent for combating strains with clindamycin-resistance phenotypes.
- Further research into MOR/α-CD could lead to new strategies against challenging bacterial infections.
Related Concept Videos
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Antimicrobial Effectiveness
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Subviral Agents
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...

